Description: Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
Home Page: www.vitrolife.com
Gustaf Werners gata 2
Gothenburg,
421 32
Sweden
Phone:
46 3 17 21 80 00
Officers
| Name | Title |
|---|---|
| Mr. Thomas Axelsson M.Sc. | Pres & CEO |
| Mr. Patrik Tolf | Chief Financial Officer |
| Mr. Claus Bisgaard | Sr. VP of Technologies |
| Mr. Rickard Ericsson | Sr. VP of Global Sales & Marketing |
| Ms. Karin Koritz Russberg | Sr. VP of HR & Sustainability |
| Ms. Daniel Forss | Sr. VP of Consumables |
| Ricardo Capella | Sr. VP Genetic Services |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 84.739 |
| Price-to-Book MRQ: | 1.6135 |
| Price-to-Sales TTM: | 8.7323 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1074 |